The ratio of hnRNP G to Tra2beta regulates alternative splicing of a dystrophin pseudo-exon, potentially explaining the tissue-specific manifestation of X-linked dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
No immediate change to dystrophinopathy management; leaves open whether hnRNP G/Tra2beta modulation alters cardiac phenotype.
Talat Nasim (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: